| Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA J Holmgren, J Adamsson, F Anjuère, J Clemens, C Czerkinsky, ... Immunology letters 97 (2), 181-188, 2005 | 215 | 2005 |
| A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection AM Harandi, K Eriksson, J Holmgren Journal of virology 77 (2), 953-962, 2003 | 201 | 2003 |
| Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens F Wegmann, KH Gartlan, AM Harandi, SA Brinckmann, M Coccia, ... Nature biotechnology 30 (9), 883-888, 2012 | 149 | 2012 |
| Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens NPH Knudsen, A Olsen, C Buonsanti, F Follmann, Y Zhang, RN Coler, ... Scientific reports 6 (1), 1-13, 2016 | 139 | 2016 |
| Differential roles of B cells and IFN-γ-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice AM Harandi, B Svennerholm, J Holmgren, K Eriksson Journal of General Virology 82 (4), 845-853, 2001 | 134 | 2001 |
| Vaccine adjuvants: a priority for vaccine research AM Harandi, D Medaglini, RJ Shattock, WG convened by EUROPRISE Vaccine 28 (12), 2363-2366, 2010 | 113 | 2010 |
| Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of … AM Harandi, B Svennerholm, J Holmgren, K Eriksson Journal of virology 75 (14), 6705-6709, 2001 | 103 | 2001 |
| Vaccine adjuvants: scientific challenges and strategic initiatives AM Harandi, G Davies, OF Olesen Expert review of vaccines 8 (3), 293-298, 2009 | 94 | 2009 |
| Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 … S Tengvall, A Lundqvist, RJ Eisenberg, GH Cohen, AM Harandi Journal of virology 80 (11), 5283-5291, 2006 | 81 | 2006 |
| Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA J Holmgren, AM Harandi, C Czerkinsky Expert review of vaccines 2 (2), 205-217, 2003 | 80 | 2003 |
| The mucosal adjuvant effect of α-galactosylceramide for induction of protective immunity to sexually transmitted viral infection M Lindqvist, J Persson, K Thörn, AM Harandi The Journal of Immunology 182 (10), 6435-6443, 2009 | 78 | 2009 |
| Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of … S Raghavan, J Nyström, M Fredriksson, J Holmgren, AM Harandi Infection and immunity 71 (12), 7014-7022, 2003 | 70 | 2003 |
| CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections AM Harandi, J Holmgren Current opinion in investigational drugs (London, England: 2000) 5 (2), 141-145, 2004 | 60 | 2004 |
| Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice J Del Campo, M Lindqvist, M Cuello, M Bäckström, O Cabrerra, J Persson, ... Vaccine 28 (5), 1193-1200, 2010 | 56 | 2010 |
| Molecular signatures of vaccine adjuvants T Olafsdottir, M Lindqvist, AM Harandi Vaccine 33 (40), 5302-5307, 2015 | 52 | 2015 |
| Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities D Boraschi, MA Alemayehu, A Aseffa, F Chiodi, J Chisi, G Del Prete, ... PLoS Negl Trop Dis 2 (6), e255, 2008 | 47 | 2008 |
| Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the … C Cheng, I Bettahi, MI Cruz-Fisher, S Pal, P Jain, Z Jia, J Holmgren, ... Vaccine 27 (44), 6239-6246, 2009 | 45 | 2009 |
| Recent developments in mucosal immunomodulatory adjuvants. AM Harandi, J Sanchez, K Eriksson, J Holmgren Current opinion in investigational drugs (London, England: 2000) 4 (2), 156-161, 2003 | 40 | 2003 |
| Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection E Schön, AM Harandi, I Nordström, J Holmgren, K Eriksson Journal of reproductive immunology 50 (2), 87-104, 2001 | 40 | 2001 |
| Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin J Adamsson, M Lindblad, A Lundqvist, D Kelly, J Holmgren, AM Harandi The Journal of Immunology 176 (8), 4902-4913, 2006 | 37 | 2006 |
